跳至内容
Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research 線上預覽
關閉線上預覽
正在查...

Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research

作者: Nikhil C Munshi; Kenneth C Anderson
出版商: New York ; London : Springer, ©2013.
版本/格式:   電子書 : 文獻 : 英語所有版本和格式的總覽
資料庫:WorldCat
提要:
Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination  再讀一些...
評定級別:

(尚未評分) 0 附有評論 - 成爲第一個。

主題
更多類似這樣的

 

在線上查詢

與資料的連結

在圖書館查詢

&AllPage.SpinnerRetrieving; 正在查詢有此資料的圖書館...

詳細書目

類型/形式: Electronic books
其他的實體格式: Print version:
Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research.
New York ; London : Springer, 2012
(OCoLC)817270653
資料類型: 文獻, 網際網路資源
文件類型: 網路資源, 電腦資料
所有的作者/貢獻者: Nikhil C Munshi; Kenneth C Anderson
ISBN: 9781461452607 1461452600 1461452597 9781461452591
OCLC系統控制編碼: 821823520
注意: Includes index.
描述: 1 online resource.
内容: Myeloma Immune and Antibody Targets --
T Cell Responses in Myeloma / Ross Brown, P. Joy Ho, John Gibson, Douglas Joshua --
Novel Antigenic Targets for Immunotherapy in Myeloma / Qing Yi --
Antibody-Based Therapies in Multiple Myeloma / Yu-Tzu Tai --
Defining Multiple Myeloma as a Target for DNA Vaccines / Surinder S. Sahota, Natalia Savelyeva, Debora Joseph-Pietras, Niklas Zojer --
Harnessing Allogeneic Immunity for Anti-myeloma Response / Roberto Bellucci, Edwin P. Alyea --
Dendritic Cells and Peptide-Based Vaccine In Multiple Myeloma / Jooeun Bae, R. H. Prabhala, Nikhil C. Munshi --
New Agents --
Novel Proteasome Inhibitors / Robert Z. Orlowski --
Newer IMiDs / Abhishek Singla, Shaji Kumar. --
Novel Agents in Multiple Myeloma / Anuj Mahindra, Jacob Laubach, Constantine Mitsiades, Paul Richardson --
Early Combination Studies in Multiple Myeloma / Alessandra Larocca, Antonio Palumbo --
The Effect of Novel Anti-myeloma Agents on Bone Metabolism / Evangelos Terpos. T cell responses in myeloma --
Novel antigenic targets for immunotherapy in myeloma --
Antibody-based therapies in Multiple Myeloma --
Defining multiple myeloma as a target for DNA gene fusion vaccines --
Harnessing allogeneic immunity for anti-myeloma response --
Dendritic cell and peptide-based vaccination in myeloma --
New Proteasome inhibitors --
Newer Imids --
New agents in myeloma --
Early Combination Studies in MM --
The effect of novel antimyeloma agents on bone metabolism --
Index.\
其他題名: Translational and clinical research
責任: edited by Nikhil C. Munshi, Kenneth C. Anderson.
更多資訊:

摘要:

This volume focuses on the biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel  再讀一些...

評論

讀者提供的評論
正在擷取GoodReads評論...
正在擷取DOGObooks的評論

標籤

成爲第一個

類似資料

相關主題:(6)

提供給讀者有關此資料的清單 (1)

確認申請

你可能已經申請過這份資料。若還是想申請,請選確認。

連結資料


<http://www.worldcat.org/oclc/821823520>
library:oclcnum"821823520"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
rdf:typeschema:Book
rdf:typeschema:MediaObject
rdf:valueUnknown value: dct
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:alternateName"Translational and clinical research"
schema:bookFormatschema:EBook
schema:contributor
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact."
schema:description"T cell responses in myeloma -- Novel antigenic targets for immunotherapy in myeloma -- Antibody-based therapies in Multiple Myeloma -- Defining multiple myeloma as a target for DNA gene fusion vaccines -- Harnessing allogeneic immunity for anti-myeloma response -- Dendritic cell and peptide-based vaccination in myeloma -- New Proteasome inhibitors -- Newer Imids -- New agents in myeloma -- Early Combination Studies in MM -- The effect of novel antimyeloma agents on bone metabolism -- Index.\"
schema:exampleOfWork<http://worldcat.org/entity/work/id/2022960558>
schema:genre"Electronic books"
schema:inLanguage"en"
schema:name"Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research"
schema:publication
schema:publisher
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=523058>
schema:url<http://site.ebrary.com/id/10634854>
schema:url<http://lib.myilibrary.com?id=424647>
schema:url
schema:workExample
schema:workExample
schema:workExample
wdrs:describedby

Content-negotiable representations

關閉視窗

請登入WorldCat 

没有帳號嗎?你可很容易的 建立免費的帳號.